Strona 92 - Najlepsi lekarze w Turcji — proszę uzyskać konsultację online

Dr. Batuhan is a dentist with six years of clinical experience. He specializes in prosthetic dentistry. He graduated from Baskent University Faculty of Dentistry. He later advanced his training at Ankara University Faculty of Dentistry in Prosthetic Dentistry.

Dr. Batuhan provides personalized dental care and focuses on improving his patients’ smiles. He is known for his commitment to quality care. He has treated hundreds of patients and has achieved high patient satisfaction.

Dr. Hakan Ölmeztürk is a respected plastic surgeon. He specializes in mommy makeover surgery, mammoplasty, liposuction, and rhinoplasty. He founded Estemita Aesthetics Clinic in Turkey. Patients often praise his work, and he receives top reviews on Bookimed.

Dr. Ölmeztürk has completed thousands of procedures. He is known for his focus on safety and quality. His clinic is accredited and uses modern technology. Many patients from other countries choose his clinic for reliable aesthetic care.

Dr. Mehmet Hanifi Kutlar is a Medical Director and Health Tourism Director. He holds a Biology degree from Turkey and completed his medical education abroad. He founded Estecapelli and Bench Turizm. His leadership covers the Middle East, Balkans, Europe, and Africa.

Dr. Kutlar has improved operational and surgical satisfaction rates in his field. He integrates research and development into his practice. His projects have received support from the Scientific and Technological Research Council of Turkey. This support highlights his dedication to innovation and quality in health tourism and medical services.

Dr. Ömer Faruk Deveci is a board-certified plastic, reconstructive, and aesthetic surgeon. He earned his medical degree from Marmara University in 2012. He completed his specialization in plastic surgery in 2018. Dr. Deveci trained internationally in Miami and Seattle. There, he focused on advanced facelift and craniofacial techniques.

He has contributed to scientific research, including a well-known flap study. Dr. Deveci has also completed his state and military service. Since 2020, he has been practicing privately. He offers care in all areas of plastic, reconstructive, and aesthetic surgery.

Dr. Burak Onvural is a board-certified microsurgeon in orthopedics and traumatology. He has over 17 years of clinical experience. He is known for his skills in treating sports injuries, joint replacements, and minimally invasive procedures such as knee and hip arthroscopy.

Dr. Onvural has worked as an orthopedic doctor for top sports clubs, including Altay FC in the Turkish Premier League. He has performed many successful surgeries, including anterior cruciate ligament reconstructions and stem cell therapies for arthritis. He received international training at the International Trauma Association in Switzerland. He is also accredited by leading orthopedic societies.

Dr. Hasan Erdem is an Associate Professor and General Surgery Specialist. He is known for his skill in obesity and metabolic surgery. Dr. Erdem has performed thousands of bariatric and metabolic procedures. He is recognized as a leading surgeon in Turkey. He holds advanced certifications, including the Laparoscopic Bariatric Surgery Hands-On Course (USA) and the Laparoscopic Colon Rectum Surgery Course.

Dr. Erdem is a member of respected organizations such as the International Federation for the Surgery of Obesity and Metabolic Disorders and the Turkish Surgical Association. He founded the Dr. HE Obesity Clinic in Istanbul. Since then, he has maintained high patient satisfaction and earned international accreditation. His work reflects a strong commitment to quality surgical care.

Dr. Kubilay Ukinc is a specialist in endocrinology and metabolic diseases. His clinical interests include diabetes, thyroid disorders, obesity, and hypertension. He also treats adrenal and pituitary diseases, as well as hormone-related disorders in both women and men. Dr. Ukinc has expertise in low blood sugar conditions.

He received his medical training at Hacettepe University and Karadeniz Technical University. He has worked in academic and clinical roles at Karadeniz Technical University, Çanakkale Onsekiz Mart University, and Istanbul Bilim University. Dr. Ukinc has broad experience in internal medicine and endocrinology. He is active in both patient care and medical education.

Areas of Interests

• Breast cancer
• Lung cancer
• Colorectal cancers
• Gynecological and urogenital cancers
• Molecular Oncology

Education:

• Kızıltepe Anatolian High School 2001
• Dicle University Faculty of Medicine 2007
• Istanbul Medeniyet University Göztepe Training and Research Hospital 2014
• Kartal City Hospital 2021
• Associate Professor of Medical Oncology 2023

Experience:

• Liv Hospital Ulus
• Adıyaman University Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital

Research:

• Phase II, Randomized, Open-Label, Multicenter Study to Comparatively Evaluate the Efficacy and Safety of GDC-9545 and Physician-Preferred Endocrine Monotherapy in Previously Treated, Estrogen Receptor Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer Patients, Other ( International), Dr. Murat Ayhan
• Phase III, Randomized, Evaluating the Efficacy and Safety of Palbociclib and Fulvestrant with Gdc-0077 Compared with Placebo in Patients with Pik3ca-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer. Double Blind, Placebo Controlled Study, Other (International), Dr. Murat Ayhan
• Randomized, Multicenter, Phase Ib/III Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Atezolizumab Compared to Intravenous Atezolizumab in Patients with Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Other (International) Dr. Murat Ayhan
• Randomized, Controlled, Multicenter, Open-Label Study Including Observation Follow-Up for PSMA-PET-Negative Patients, Investigating the Efficacy and Safety of Addition of Apalutamide to Radiotherapy and LHRH Agonist in PSMA-PET-Positive High-Risk Hormone-Sensitive Prostate Cancer Patients, Other (International) Dr. Murat Ayhan
• Biomarker Study to Identify Patients with Advanced Stage Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations-42756493BLC0002, Other (International), Dr. Murat Ayhan
• Publications:
• Ayhan M, Turan N, Köstek O, et all. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology? Curr Probl Cancer. 2021 Jun;45(3):100670. doi: 10.1016/j.currproblcancer.2020.100670.
• Ayhan M, Odabas H, Turan N, et all. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience. J Chemother. 2021 Nov;33(7):499-508. doi: 10.1080/1120009X.2021.1923153.
• Ayhan M, Laçin Ş, Özyükseler DT, et all. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? J Oncol Pharm Pract. 2021 Sep;27(6):1461-1467. doi: 10.1177/10781552211015762.
• Ayhan M, Abamor E, Coban Kokten S, et al. Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. EJMI 2022;6(2):165–175.
• Ayhan M, Terzioglu K. Experience With Rapid Drug Desensitization With Chemotherapeutics; A SingleCentre Retrospective Study. EJMI 2021;5(3):380–387.
• Doğan A, AYHAN M. Survival analysis of patients with triple-negative breast cancer: a single-center experience. Journal of Oncological Sciences, 8(2), 94-99., Doi: 10.37047/jos.2022-89749
• Terzioğlu K, Ayhan M. Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis? J Oncol Pharm Pract. 2021 Nov 30:10781552211050084. doi: 10.1177/10781552211050084.
• Tacar SY, Selcukbiricik F, Yilmaz M, Erturk K, Murat Sarici A, Gulturk I, Ayhan M, Tural D. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study. Melanoma Res. 2021 Oct 1;31(5):449-455. doi: 10.1097/CMR.0000000000000744.
• Özyurt E, Özçelik S, Sürmeli H, Çelik M, Ayhan M, Özçelik M. Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient? J Oncol Pharm Pract. 2022 Mar;28(2):462-465. doi: 10.1177/10781552211038136.
• Dülgar Ö, Öven BB, Atcı MM, Arıkan R, Ay S, Ayhan M, Selvi O, Ozyukseler DT, Bayram E, Özcan E, Yasin Aİ, Gümüş M. Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy? Expert Rev Anticancer Ther. 2022 Jul;22(7):773-780. doi: 10.1080/14737140.2022.2076670.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study. J Cancer Res Clin Oncol. 2022 Jun;148(6):1501-1508. doi: 10.1007/s00432-021-03748-7.
• Volume I, Kucukarda A, Atcı MM, Ayhan M, et all. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori. 2022 Feb;108(1):19-25. doi: 10.1177/03008916211037739.
• Dogan I, Ayhan M, Gurbuz M, et all. The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study. Medicine (Baltimore). 2022 Sep 2;101(35):e30147. doi: 10.1097/MD.0000000000030147.
• Ozcelik M, Oyman A, Cil I, Duzgun O, Ozkan OF, Ayhan M. Cytoreductive Surgery versus Systemic Chemotherapy alone in Isolated Peritoneal Carcinomatosis of Colorectal Origin. J Coll Physicians Surg Pak. 2021 Nov;31(11):1308-1313. doi: 10.29271/jcpsp.2021.11.1308.
• Başoğlu T, Sakin A, Erol C, Ayhan M, et all. Real life experienceof patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study. J Chemother. 2022 May 17:1-8. doi: 10.1080/1120009X.2022.2073159.
• Özdemir Ö, Zengel B, Yildiz Y, Ayhan M, et all. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study. Anticancer Drugs. 2022 Aug 1;33(7):663-670. doi: 10.1097/CAD.0000000000001310.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study). J Cancer Res Clin Oncol. 2022 Sep 1. doi: 10.1007/s00432-022-04252-2.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study. Future Oncol. 2022 Jul;18(23):2573-2582. doi: 10.2217/fon-2022-0083.
• Topcu A, Atci MM, Secmeler S, Besiroglu M, Ayhan M, Ozkan M, Bozkurt O, Urakci Z, Ay S, Geredeli C, Yasin AI, Turk HM. Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. Future Oncol. 2021 Nov;17(31):4157-4169. doi: 10.2217/fon-2021-0398.
• Bilgin B, Sendur MAN, Yucel S, Ayhan M, et all. Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study. J Cancer Res Clin Oncol. 2021 Jul;147(7):2145-2152. doi: 10.1007/s00432-020-03501-6.
• Atci MM, Akagunduz B, Demir M, Arikan R, Ay S, Ozer M, Ayhan M, Cil I, Demir N, Ozyurt N, Karakaya G, Cevik GT, Onder AH, Selvi O, Sakin A. The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study. J Chemother. 2023 Feb;35(1):19-28. doi: 10.1080/1120009X.2022.2040770.
• Tataroglu Ozyukseler D, Ay S, Turan M, Alkan G, Ayhan M, Surmeli H, et al. The Systemic Inflammation Response Index as a Prognostic Marker in Advanced Pancreatic Cancer. EJMI 2022;6(3):367–373.
• Yıldız F, Ayhan M, Demir H, et all. Comparing the efficacy of cabazitaxel in secondline and third-Line treatment of metastatic castration-resistant prostate cancer: a multi-center experience from Turkey. International Journal of Contemporary Medical Research, 7(9), 112-116.,Doi: 10.21276/ijcmr.2020.7.9.30
• Terzioğlu K, Ayhan M. Distribution of allergens detected on patch tests of patients with allergic contact dermatitis and investigation of their atopic background. Annals of Medical Research, 29(5), 422-426., doi: 10.5455/annalsmedres.2021.07.490
• Arikan R, Atci MM, Ay S, Ayhan M, et all Prognostic significance of mucinous histology in left sided metastatic colorectal cancers with wild type RAS and evaluation of backbone chemotherapy regimens. Oncol Lett. 2023 Apr 5;25(5):208. doi: 10.3892/ol.2023.13795.
• Almuradova E, Yalcin S, Arıkan R, Ayhan M, Demir H, Cevik GT, Karaca M, Petekkaya I, Karabulut B. Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study. Cureus 2023 May 17;15(5):e39119. doi: 10.7759/cureus.39119.
• Topcu A, Besiroglu M, Atci MM, Ayhan M, et all. Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data. EJMI 2023;7(2):153–161. DOI: 10.14744/ejmi.2023.22720
• Book Writing:
• Drug interactions and side effects of targeted agents, Section name: (Small molecule tyrosine kinase inhibitors; ROS-1 targeted therapies (Crizotinib, Seritinib)) (2021)., AYHAN MURAT, Turkish Clinics Journal of Medical Sciences, Editor: Mehmet Aliustaoglu, Publishing number:1, Number of Pages 92, ISBN:978-625-401- 466-6, Turkish
• Approach to gastrointestinal stromal tumors and neuroendocrine tumors, Department name: (Medical approach in primary non-gastrointestinal neuroendocrine tumors) (2020)., AYHAN MURAT, Akademisyen Yayınevi, Editor: Anılır Ender, Number of editions: 1, Number of Pages 382, ISBN: 9786052585719, Turkish
• Internal medicine emergencies, Department name: (Oncological emergencies) (2022)., YILDIRIM SEDAT, AYHAN MURAT, Efe Academic Publishing, Editor: Serdar Olt, Number of editions: 1, Number of Pages 232, ISBN: 978-625-8324-66- 2, Turkish
• Physicians' chemotherapy cancer drug manual 2020, Section name: (Common chemotherapy regimens in clinical practice) (2022)., SÜMBÜL AHMET TANER, ALKAN ALI, AKSOY ASUDE, AYHAN MURAT, et all, Türkiye Klinikleri Journal of Medical Sciences, Editor: EDWAR CHU, VINCENT T. DEVITA, SAADDETIN KILIÇKAP, CEMIL BILIR, SELÇUK SEBER, Number of editions: 1, Number of pages 772, ISBN: 978-625-401-290- 7, Turkish (Book Translation)

edukacja

Wydział Lekarski Uniwersytetu İnönü (angielski) 1995-2002

Doświadczenie zawodowe

Premier SHÇ.EK Dyrekcja Generalna Medycyny Instytucjonalnej (2003)

Wydział Lekarski Uniwersytetu Erciyes, specjalizacja z chirurgii ogólnej 2011

Szkolenie z zakresu podstawowych i zaawansowanych interwencji endoskopowych na Uniwersytecie Yüzüncü Yıl 2011

Szpital w Stambule /Van 2011

Prywatny Szpital Malatya / Malatya2012

Centrum Medyczne Bilgi Keçiören /Ankara 2013

Prywatny szpital Koru Sincan Sincan/Ankara 2013

Główne Centrum Medyczne /Klinika Baku Azerbejdżan/Baku 2013

Prywatny szpital Koru Ankara Uniwersytetu Yüksek İhtisas 2019

Prywatny szpital Ankara Koru / Ankara 2019

Zainteresowania medyczne

otyłość laparoskopowa
Laparoskopowe operacje przepuklin brzusznych i pachwinowych (najnowocześniejszymi technikami)

Poporodowe laparoskopowe diastasis recti (powstanie wypukłości w górnej środkowej części brzucha w wyniku rozdzielenia się mięśni w tkance brzusznej) i przepukliny brzuszne powyżej pępka i pępka, zarówno naprawa rozstępu prostego, jak i naprawa przepukliny brzusznej ze skóry metodą laparoskopową metoda Scola po raz pierwszy w Turcji laparoskopowa przepuklina żołądka i operacja antyrefluksowa).

Laparoskopowe operacje pęcherzyka żółciowego, w tym oczyszczenie dróg żółciowych za pomocą płukania przeztorbielowatego przewodu żółciowego u pacjentów ze osadem żółciowym i kamieniami w przewodzie żółciowym mniejszym niż 5 mm, wykonywane podczas tej samej sesji

Laparoskopowe operacje pęcherzyka żółciowego u kobiet w ciąży w II i III trymestrze, czyli po 12 tygodniu ciąży

Laparoskopowa wycięcie wyrostka robaczkowego w ciąży

Schorzenia odbytu, szczeliny odbytu, wszelkiego rodzaju operacje hemoroidów wewnętrznych i zewnętrznych, operacje szczeliny odbytu, przetoki odbytu

Operacje tarczycy i nowotwory, operacje przytarczyc i nowotwory

Choroby piersi i chirurgia raka piersi

Chirurgia onkologiczna; operacje wątroby i pęcherzyka żółciowego oraz dróg żółciowych, operacje raka żołądka, operacje raka okrężnicy i resekcje wątroby w przypadku przerzutowych guzów wątroby

Dr. Idris Sertbas is a skilled neurosurgeon with experience in both adult and pediatric brain and spine surgeries. He performs complex procedures such as brain and cerebellum tumor surgeries. He also treats children with conditions like hydrocephalus, tethered cord, and craniosynostosis. Dr. Sertbas is experienced in advanced spine surgeries, including stabilization for disc herniation, vertebroplasty, and kyphosis surgery.

He is trained in neuromodulation surgeries, such as deep brain stimulation for Parkinson’s disease, epilepsy stimulation, and spinal cord stimulation for chronic pain. He also performs procedures for trigeminal neuralgia, hemifacial spasm, and baclofen pump implantation for severe spasticity.

Dr. Sertbas graduated from Sivas Cumhuriyet University and completed his neurosurgery training at Ankara Training and Research Hospital. He has worked at Bartın State Hospital and Istanbul Yeni Yüzyıl University. He now practices at the Neurosurgery Clinic of Liv Vadistanbul Hospital.

Urodził się w Ankarze w 1980 roku, zdobył wykształcenie podstawowe i średnie w Artvin, swoim rodzinnym mieście. Ukończył Inebolu High School w 1997 roku i rozpoczął studia na Wydziale Lekarskim Uniwersytetu w Ankarze w tym samym roku. Otrzymał tytuł doktora medycyny w 2003 roku i w tym samym roku uzyskał wysoki wynik na egzaminie specjalizacyjnym.

Rozpoczął naukę specjalizacji z kardiologii w Katedrze Kardiologii Wydziału Lekarskiego Uniwersytetu Gazi i w 2008 roku uzyskał tytuł specjalisty kardiologa.

Podczas obowiązkowej służby wojskowej pełnił funkcję kardiologa interwencyjnego w Szpitalu Edukacyjno-Badawczym Rize.

Pracował w dziedzinie elektrofizjologii z prof. dr. Remzi Karaoğuzem w szpitalu Ankara Güven. Został profesorem nadzwyczajnym w styczniu 2014 r., a profesorem w 2023 r.

W trakcie swojej kariery akademickiej opublikował wiele publikacji naukowych, które zostały opublikowane w kraju i za granicą i otrzymały wysokie cytowania. Oprócz edukacji medycznej i usług leczenia klinicznego świadczy usługi patentowe i konsultingowe dla inżynierii medycznej. Jest członkiem krajowych i międzynarodowych stowarzyszeń naukowych. Obecnie pracuje w dziedzinie kardiologii interwencyjnej i elektrofizjologii serca w Klinice Kardiologii w Szpitalu Ankara Koru Çukurambar.

Jego zainteresowania medyczne obejmują:

Badanie elektrofizjologiczne serca (EPS) i terapia ablacyjna

Implantacja i nadzorowanie rozruszników serca

Kardiologia interwencyjna

Areas of Interests

• Demyelinating Diseases and MS
• Peripheral Neuropathy and Motor Neuron Disease (ALS)
• Neuromuscular Junction Diseases (MG)

Education 

• M.Sc. Faculty of Medicine, Ondokuz Mayıs University  1990
• Specialization in Medicine  Neurology,  Ankara Training and Research Hospital 1997
• Minor Specialization  Clinical Neurophysiology, Medical Specialization Board 2011

Experience

• Doctor MoH Kastamonu and Samsun Health Center No. 7 1990-1992
• Dr. Res.Assist. Ankara Training and Research Hospital Neurology Clinic 1992-1997
• Assoc. Dr. Abant İzzet Baysal University Düzce Faculty of Medicine 1999-2006
• Assoc.Dr. Duzce University Faculty of Medicine 2007-2011
• Prof.Dr  Duzce University Faculty of Medicine  2011-